The AHDC1 Knockout HEK293T Polyclonal Cells comprise a CRISPR/Cas9-edited population of human embryonic kidney cells with targeted disruption of the AHDC1 gene. This polyclonal knockout model, built on the highly transfectable HEK293T line, provides a loss-of-function system to study AHDC1-mediated transcriptional repression and its role in Wnt/??-catenin signaling.
HEK293T cells are a derivative of the HEK293 human embryonic kidney line, stably expressing the SV40 large T-antigen. This T-antigen promotes episomal replication of plasmids with an SV40 origin, yielding high transgene expression. The line’s exceptional transfectability and robust growth make it a preferred host for recombinant protein production, lentiviral packaging, and CRISPR-based genome engineering, ensuring efficient knockout generation and downstream assay compatibility.
AHDC1 functions as a transcriptional repressor that negatively regulates Wnt/??-catenin signaling by interacting with ??-catenin and TCF/LEF factors, including TCF4/TCF7L2, at Wnt-responsive promoters. This repression suppresses the expression of downstream targets such as MYC, CCND1, and AXIN2. AHDC1 also associates with chromatin modifying components, including the SWI/SNF ATPase BRG1 (SMARCA4) and HDAC2. In the canonical pathway, Wnt ligands bind Frizzled receptors and LRP5/6 co-receptors, leading to ??-catenin stabilization and nuclear translocation. ??-catenin then partners with TCF/LEF to activate transcription, a process that AHDC1 normally counteracts. Disruption of AHDC1 thus lifts this repression, mimicking persistent Wnt pathway activation.
In HEK293T cells, loss of AHDC1 through CRISPR editing provides a robust system to study Wnt/??-catenin hyperactivation. Because these cells express core Wnt pathway components, AHDC1 knockout likely enhances ??-catenin-driven transcription, offering a convenient model for mechanistic investigations. This tool is particularly useful for modeling the molecular underpinnings of Xia-Gibbs syndrome, a condition linked to intellectual disability and developmental anomalies, and for exploring the role of AHDC1 in chromatin organization and neurodevelopment-related gene regulation. The polyclonal knockout population enables studies on the interplay between AHDC1 and chromatin remodelers, informing how disruptions in repressive complexes contribute to disease.
Functional applications include mechanistic dissection of Wnt/??-catenin signaling, high-throughput screening of pathway modulators, and comprehensive protein interaction mapping. Researchers can employ TOPFlash/FOPFlash luciferase reporter assays to quantify ??-catenin-driven transcription, ChIP-qPCR to evaluate AHDC1 and associated factors at chromatin, co-immunoprecipitation to probe interactions with ??-catenin, TCF4, BRG1, or HDAC2, and RNA-seq for transcriptome-wide analysis. Cell proliferation assays (CCK-8) and immunofluorescence further enable phenotypic assessment. This polyclonal knockout population serves as a robust platform for both hypothesis-driven research and preclinical drug discovery. For inquiries and technical support, please contact Ascent Research.
